US Patent Issued to Gilead Sciences on Jan. 13 for "Substituted dipyrido[1,2-a:1',2'-dpyrazines for treating viral infections" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,388, issued on Jan. 13, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Substituted dipyrido[1,2-a:1',2'-dpyrazines for treating viral infections" was invented by Manoj C. Desai (Martinez, Calif.), Mingzhe Ji (Union City, Calif.), Haolun Jin (Foster City, Calif.), Hyung-Jung Pyun (Fremont, Calif.) and Teresa Alejandra Trejo Martin (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I):including stereoisomers and pharmaceutically acceptable salts thereof, wherein L, R1, R5, W, X, Y1, Y2, ...